The effect of SARS-CoV-2 D614G mutation on BNT162b2 vaccine-elicited neutralization

被引：38

作者：

Zou, Jing ^{[1
]}

Xie, Xuping ^{[1
]}

Fontes-Garfias, Camila R. ^{[1
]}

Swanson, Kena A. ^{[2
]}

Kanevsky, Isis ^{[2
]}

Tompkins, Kristin ^{[2
]}

Cutler, Mark ^{[2
]}

Cooper, David ^{[2
]}

Dormitzer, Philip R. ^{[2
]}

Shi, Pei-Yong ^{[1
,3
,4
,5
]}

机构：

[1] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA

[2] Pfizer, Pearl River, NY 10965 USA

[3] Univ Texas Med Branch, Inst Translat Sci, Galveston, TX 77555 USA

[4] Univ Texas Med Branch, Sealy Inst Vaccine Sci, Galveston, TX 77555 USA

[5] Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA

来源：

NPJ VACCINES | 2021年 / 6卷 / 01期

关键词：

D O I：

10.1038/s41541-021-00313-8

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Initial COVID-19 vaccine candidates were based on the original sequence of SARS-CoV-2. However, the virus has since accumulated mutations, among which the spike D614G is dominant in circulating virus, raising questions about potential virus escape from vaccine-elicited immunity. Here, we report that the D614G mutation modestly reduced (1.7-2.4-fold) SARS-CoV-2 neutralization by BNT162b2 vaccine-elicited mouse, rhesus, and human sera, concurring with the 95% vaccine efficacy observed in clinical trial.

引用

页数：4

共 50 条

[1] The effect of SARS-CoV-2 D614G mutation on BNT162b2 vaccine-elicited neutralization
Jing Zou
Xuping Xie
Camila R. Fontes-Garfias
Kena A. Swanson
Isis Kanevsky
Kristin Tompkins
Mark Cutler
David Cooper
Philip R. Dormitzer
Pei-Yong Shi
npj Vaccines, 6
[2] Neutralization of SARS-CoV-2 Omicron by BNT162b2 mRNA vaccine-elicited human sera
Muik, Alexander
Lui, Bonny Gaby
Wallisch, Ann-Kathrin
Bacher, Maren
Muehl, Julia
Reinholz, Jonas
Ozhelvaci, Orkun
Beckmann, Nina
Garcia, Ramon de la Caridad Gueimil
Poran, Asaf
Shpyro, Svetlana
Finlayson, Andrew
Cai, Hui
Yang, Qi
Swanson, Kena A.
Tuereci, Oezlem
Sahin, Ugur
SCIENCE, 2022, 375 (6581) : 678 - +
[3] Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine-elicited human sera
Muik, Alexander
Wallisch, Ann-Kathrin
Saenger, Bianca
Swanson, Kena A.
Muehl, Julia
Chen, Wei
Cai, Hui
Maurus, Daniel
Sarkar, Ritu
Tuereci, Oezlem
Dormitzer, Philip R.
Sahin, Ugur
SCIENCE, 2021, 371 (6534) : 1152 - +
[4] SARS-CoV-2 Neutralization with BNT162b2 Vaccine Dose 3
Falsey, Ann R.
Frenck, Robert W., Jr.
Walsh, Edward E.
Kitchin, Nicholas
Absalon, Judith
Gurtman, Alejandra
Lockhart, Stephen
Bailey, Ruth
Swanson, Kena A.
Xu, Xia
Koury, Kenneth
Kalina, Warren
Cooper, David
Zou, Jing
Xie, Xuping
Xia, Hongjie
Tuereci, Ozlem
Lagkadinou, Eleni
Tompkins, Kristin R.
Shi, Pei-Yong
Jansen, Kathrin U.
Sahin, Ugur
Dormitzer, Philip R.
Gruber, William C.
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (17): : 1627 - 1629
[5] Detection of the SARS-CoV-2 D614G Mutation Using VirSNiP SARS-CoV-2 Spike D614G Assay
Chen, Chih-Chieh
Er, Tze-Kiong
CLINICAL LABORATORY, 2022, 68 (06) : 1305 - 1308
[6] Neutralization of SARS-CoV-2 Variants by Serum from BNT162b2 Vaccine Recipients
Valleriani, Fabrizia
Mancuso, Elisa
Vincifori, Giacomo
Teodori, Liana
Di Marcantonio, Lisa
Spedicato, Massimo
Leone, Alessandra
Savini, Giovanni
Morelli, Daniela
Bonfini, Barbara
Lorusso, Alessio
VIRUSES-BASEL, 2021, 13 (10):
[7] Mutation D614G increases SARS-CoV-2 transmission
Arora, Prerna
Poehlmann, Stefan
Hoffmann, Markus
SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2021, 6 (01)
[8] The virological impacts of SARS-CoV-2 D614G mutation
Wang, Chenxi
Zheng, You
Niu, Zubiao
Jiang, Xiaoyi
Sun, Qiang
JOURNAL OF MOLECULAR CELL BIOLOGY, 2021, 13 (10) : 712 - 720
[9] Mutation D614G increases SARS-CoV-2 transmission
Prerna Arora
Stefan Pöhlmann
Markus Hoffmann
Signal Transduction and Targeted Therapy, 6
[10] Biosensing Detection of the SARS-CoV-2 D614G Mutation
Zhang, Yang
Xi, Hui
Juhas, Mario
TRENDS IN GENETICS, 2021, 37 (04) : 299 - 302

← 1 2 3 4 5 →